Luminex Corporation (LMNX)

NASDAQ
36.85
-0.05(-0.14%)
After Hours
36.85
0.00(0.00%)
- Real-time Data
  • Volume:
    301,232
  • Bid/Ask:
    36.66/36.94
  • Day's Range:
    36.82 - 36.95

LMNX Overview

Prev. Close
36.9
Day's Range
36.82-36.95
Revenue
528.08M
Open
36.87
52 wk Range
20.61-41.25
EPS
0.5
Volume
301,232
Market Cap
1.74B
Dividend (Yield)
0.40
(1.08%)
Average Vol. (3m)
1,105,485
P/E Ratio
73.80
Beta
0.58
1-Year Change
24.7%
Shares Outstanding
47,311,982
Next Earnings Date
Aug 09, 2021
What is your sentiment on Luminex Corporation?
or
Market is currently closed. Voting is open during market hours.

Luminex Corporation News

  • Luminex declares $0.10 dividend
    • BySeeking Alpha-

    Luminex (NASDAQ:LMNX) declares $0.10/share quarterly dividend, in line with previous.Forward yield 1.09%Payable July 8; for shareholders of record June 17; ex-div June 16.See LMNX...

  • Tesla, Alibaba and Uber Rise Premarket
    • ByInvesting.com-
    • 16

    By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, April 12th. Please refresh for updates. Nuance Communications (NASDAQ:NUAN) stock soared 22%...

Luminex Corporation Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellSellStrong BuyStrong Buy
SummaryStrong SellStrong SellSellStrong BuyStrong Buy

Luminex Corporation Company Profile

Luminex Corporation Company Profile

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Read More
  • 🔴 LMNX: now set to climb; short term holding.
    0
    • go go https://www.statesman.com/business/20200327/austin-based-luminex-receives-fda-authorization-for-coronavirus-test?template=ampart&utm_source=SND&utm_medium=Twitter&utm_campaign=statesman&__twitter_impression=true
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.